GB9322014D0
(en)
|
1993-10-26 |
1993-12-15 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
GB9501841D0
(en)
*
|
1995-01-31 |
1995-03-22 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
US5612053A
(en)
*
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
GB9515182D0
(en)
|
1995-07-24 |
1995-09-20 |
Co Ordinated Drug Dev |
Improvements in and relating to powders for use in dry powder inhalers
|
US6017963A
(en)
*
|
1995-11-14 |
2000-01-25 |
Euro-Celtique, S.A. |
Formulation for intranasal administration
|
US20020052310A1
(en)
|
1997-09-15 |
2002-05-02 |
Massachusetts Institute Of Technology The Penn State Research Foundation |
Particles for inhalation having sustained release properties
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US5871010A
(en)
*
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
FR2756739B1
(fr)
*
|
1996-12-05 |
2000-04-28 |
Astra Ab |
Nouvelle formulation de budesonide
|
SE9700133D0
(sv)
*
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
EP1006794B1
(en)
|
1997-03-12 |
2007-11-28 |
Robert W. Esmond |
A method for treating or preventing alzheimer's disease
|
US7052678B2
(en)
|
1997-09-15 |
2006-05-30 |
Massachusetts Institute Of Technology |
Particles for inhalation having sustained release properties
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6956021B1
(en)
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
US6191154B1
(en)
|
1998-11-27 |
2001-02-20 |
Case Western Reserve University |
Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
EP1238661A1
(en)
|
1999-10-12 |
2002-09-11 |
Kaken Pharmaceutical Co., Ltd. |
Powdery inhalational preparations and process for producing the same
|
CN1188111C
(zh)
|
1999-10-29 |
2005-02-09 |
耐科塔医药公司 |
分散性得到改进的干粉组合物
|
AU2001230533A1
(en)
*
|
2000-02-04 |
2001-08-14 |
Kissei Pharmaceutical Co. Ltd. |
Powdered preparation for inhalation and powder inhalant containing the same packed
|
MXPA02008403A
(es)
|
2000-02-28 |
2004-09-27 |
Vectura Ltd |
Mejoras en o relacionadas con el suministro de farmacos por via oral.
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
AU2001269261B2
(en)
*
|
2000-06-27 |
2005-11-17 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
PT1296651E
(pt)
*
|
2000-06-27 |
2008-02-12 |
Vectura Ltd |
Método para fazer partículas para serem usadas numa composição farmacêutica
|
EP2298285A3
(en)
|
2000-11-30 |
2011-07-27 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
US8580306B2
(en)
*
|
2000-11-30 |
2013-11-12 |
Vectura Limited |
Particles for use in a pharmaceutical composition
|
EP1345629A2
(en)
|
2000-12-29 |
2003-09-24 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having sustained release properties
|
WO2003020197A1
(en)
|
2001-09-05 |
2003-03-13 |
Vectura Limited |
Improvements in or relating to the delivery of oral drugs
|
PT1455755E
(pt)
|
2001-11-20 |
2013-06-18 |
Civitas Therapeutics Inc |
Composições particuladas melhoradas para distribuição pulmonar
|
KR100958235B1
(ko)
|
2001-12-19 |
2010-05-17 |
노바르티스 아게 |
아미노글리코시드의 폐 전달
|
JP2005527508A
(ja)
|
2002-03-07 |
2005-09-15 |
ヴェクトゥラ リミテッド |
経口デリバリー用急速溶融多粒子製剤
|
ATE385193T1
(de)
|
2002-03-20 |
2008-02-15 |
Mannkind Corp |
Inhalationsgerät
|
WO2004073729A1
(ja)
|
2003-02-21 |
2004-09-02 |
Translational Research Ltd. |
薬物の経鼻投与用組成物
|
MXPA05010379A
(es)
|
2003-03-27 |
2006-05-31 |
Bioactis Ltd |
Aparato para administrar una medicina en polvo en la cavidad intranasal.
|
ITMI20040795A1
(it)
*
|
2004-04-23 |
2004-07-23 |
Eratech S R L |
Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa
|
EP1785145A4
(en)
|
2004-08-10 |
2008-08-13 |
Translational Res Ltd |
TRANSNASAL COMPOSITION WITH IMMEDIATE EFFECT AND HIGH RESORBIBILITY
|
CA2575692C
(en)
|
2004-08-20 |
2014-10-14 |
Mannkind Corporation |
Catalysis of diketopiperazine synthesis
|
KR20150039211A
(ko)
|
2004-08-23 |
2015-04-09 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
EP1657278A1
(en)
|
2004-11-12 |
2006-05-17 |
SOLVAY (Société Anonyme) |
Coated particles of calcium carbonate having a high specific surface
|
WO2007033372A2
(en)
|
2005-09-14 |
2007-03-22 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
|
US20070172430A1
(en)
*
|
2006-01-20 |
2007-07-26 |
Nastech Pharmaceutical Company Inc. |
Dry powder compositions for rna influenza therapeutics
|
MX360812B
(es)
|
2006-02-22 |
2018-11-16 |
Mannkind Corp |
Un método para mejorar las propiedades farmacéuticas de micropartículas que contienen dicetopiperazina y un agente activo.
|
US8337817B2
(en)
|
2006-12-26 |
2012-12-25 |
Shin Nippon Biomedical Laboratories, Ltd. |
Preparation for transnasal application
|
MX395141B
(es)
|
2008-06-13 |
2025-03-24 |
Mannkind Corp |
Inhalador de polvo y sistema para suministro de farmaco.
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
CA2728523C
(en)
|
2008-06-20 |
2020-03-10 |
Mannkind Corporation |
An interactive apparatus and method for real-time profiling of inhalation efforts
|
JP5936353B2
(ja)
*
|
2008-07-18 |
2016-06-22 |
プロソニックス リミテッドProsonix Limited |
フルチカゾン粒子の結晶化度を改善する方法
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
HUE045917T2
(hu)
|
2009-02-26 |
2020-01-28 |
Glaxo Group Ltd |
4-{(lR)-2-[(6-(2-[(2,6-Diklórbenzil)-oxi}-etoxi}-hexil)-amino]-l-hidroxietil}-2-(hidroximetil)-fenolt tartalmazó gyógyszerkészítmények
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
WO2010131486A1
(en)
|
2009-05-15 |
2010-11-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal pharmaceutical compositions with improved pharmacokinetics
|
TWI547487B
(zh)
|
2009-06-12 |
2016-09-01 |
曼凱公司 |
具限定比表面積之二酮基哌微粒子
|
WO2011013003A2
(en)
|
2009-07-31 |
2011-02-03 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal granisetron and nasal applicator
|
JP5784622B2
(ja)
|
2009-11-03 |
2015-09-24 |
マンカインド コーポレ−ション |
吸入活動をシミュレートするための装置及び方法
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
RU2571331C1
(ru)
|
2010-06-21 |
2015-12-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
RU2569776C2
(ru)
|
2011-04-01 |
2015-11-27 |
Маннкайнд Корпорейшн |
Блистерная упаковка для фармацевтических картриджей
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
AU2012328885B2
(en)
|
2011-10-24 |
2017-08-31 |
Mannkind Corporation |
Methods and compositions for treating pain
|
BR112015000529B1
(pt)
|
2012-07-12 |
2022-01-11 |
Mannkind Corporation |
Inalador de pó seco
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
ES2928365T3
(es)
|
2013-03-15 |
2022-11-17 |
Mannkind Corp |
Composiciones de dicetopiperazina microcristalina, métodos de preparación y uso del mismo
|
MX375448B
(es)
|
2013-07-18 |
2025-03-06 |
Mannkind Corp |
Composiciones farmacéuticas en polvo seco estables al calor y métodos.
|
JP2016530930A
(ja)
|
2013-08-05 |
2016-10-06 |
マンカインド コーポレイション |
通気装置及び方法
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
US11744967B2
(en)
|
2017-09-26 |
2023-09-05 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal delivery devices
|
CA3178819A1
(en)
|
2020-05-26 |
2021-12-02 |
Chuanhai Cao |
Cannabinoid compositions and dosage forms for intranasal or inhalational delivery
|